msa kumar (11 Ergebnisse)

Zustand: New.

Zustand: New.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Soft cover. Zustand: New. Various global studies over the decades have shown that only a handful of family businesses survive beyond the third generation, while more than 90 percent flounder. Why? What is the secret sauce that keeps these organizations going strong from one generation to the next? Can their models be successfully replicated by other family businesses? For the first time, two entrepreneurs, a family business consultant and a senior journalist-all experts in their fields-have teamed up to understand why only some family businesses survive beyond the third generation and how other businesses can follow the same blueprint for longevity. With a special focus on micro, small and medium enterprises, Beyond Three Generations studies twelve family-run enterprises across industries. While not traditionally large businesses, all of these-Aravind Eye Care System, Bhima Jewellers, Dodla Dairy, Eastern Condiments, ELICO Ltd, Evolve Back, Gera Developments, House of Anita Dongre, IBS Software, OmniActive Health Technologies, Popular Automobiles and Sandu Pharmaceuticals-are well recognized within their sectors, mostly with turnovers of more than ?1,000 crore. The authors document how these companies started small, built solid foundations, set up systems and processes, and established a culture that would last. They use their keen insight and expertise to reveal not only the critical drivers that help create lasting organizations, but also how one can balance the two key dimensions to building any family business-family and business.

Hardcover. Zustand: New. Various global studies over the decades have shown that only a handful of family businesses survive beyond the third generation, while more than 90 percent flounder. Why? What is the secret sauce that keeps these organizations going strong from one generation to the next? Can their models be successfully replicated by other family businesses? For the first time, two entrepreneurs, a family business consultant and a senior journalist-all experts in their fields-have teamed up to understand why only some family businesses survive beyond the third generation and how other businesses can follow the same blueprint for longevity. With a special focus on micro, small and medium enterprises, Beyond Three Generations studies twelve family-run enterprises across industries. While not traditionally large businesses, all of these-Aravind Eye Care System, Bhima Jewellers, Dodla Dairy, Eastern Condiments, ELICO Ltd, Evolve Back, Gera Developments, House of Anita Dongre, IBS Software, OmniActive Health Technologies, Popular Automobiles and Sandu Pharmaceuticals-are well recognized within their sectors, mostly with turnovers of more than ?1,000 crore. The authors document how these companies started small, built solid foundations, set up systems and processes, and established a culture that would last. They use their keen insight and expertise to reveal not only the critical drivers that help create lasting organizations, but also how one can balance the two key dimensions to building any family business-family and business.

Paperback. Zustand: Brand New. 256 pages. 8.46x5.51x0.59 inches. In Stock.

Buch. Zustand: Neu. Neuware - The authors document how these companies started small, built solid foundations, set up systems and processes, and established a culture that would last.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume is based on a very successful meeting on organ transplantation that was held in Kuwait in 1990 under the auspices of the Middle East Society for Organ Transplantation. An international group of organ transplant experts attended this conference and their contributions and deliberations have been recent1y updated to produce this definitive and authoritative summary of current clinic al practice in organ transplantation. The initial chapters appropriately focus on the immunology of organ trans plantation with special emphasis on the initial events in the induction of alloreactivity, the mechanisms of rejection, and the potential for tolerance induction. A strong emphasis is placed on the diagnosis of rejection by cellular analysis. The section on immunosuppression deals with several new areas of clinical therapy. The section on renal transplantation is unique in several respects, the long-term results from various countries, including the Middle East, are summarized, the use of living unrelated donors and of ABO incom patible donors - all strategies to maximize organ availability - are presented.

Gebunden. Zustand: New.

Hardcover. Zustand: Brand New. 616 pages. 9.21x6.14x1.31 inches. In Stock.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - One: Historical Reflections.- 1. Reflections on the development of organ transplantation.- Two: Immunology of Organ Transplantation.- 2. Cellular and molecular mechanisms of allograft rejection.- 3. What does the alloreactive T cell see .- 4. HLA matching and organ transplantation.- 5. An effective strategy for transplantation of highly sensitized patients.- 6. Rapid lymphocyte crossmatching for renal transplantation.- Three: Organ Allograft Rejection.- 7. Fifteen-year experience with fine needle aspiration biopsies at the University of Helsinki.- 8. Study of antibody specificity in highly sensitized patients using human monoclonal antibody technology.- 9. Idiotypic-Antiidiotypic antibody interaction and renal transplant survival.- Four: Immunosuppression.- 10. Transplantation and blood transfusion in 1990.- 11. Quadruple-drug immunosuppressive induction treatments for immunological high-risk patients in cadaveric renal transplantation using poly-and monoclonal antibodies.- 12. Sequential combination immunotherapy for cadaveric renal transplantation: OKT3 versus rabbit ATG induction.- 13. Multi-organ transplant experience with OKT3 and strategies for use at the University of Cincinnati Medical Center.- 14. Cyclosporine withdrawal in renal transplant recipients maintained on azathioprine, prednisone and cyclosporine.- 15. Early experience with FK 506 in liver transplantation.- 16. Deoxyspergualin. A novel immunosuppressant: experimental and clinical studies.- 17. Preliminary results with FK 506 in pancreas grafting in a nonhuman primate model.- 18. The effect of DST on graft outcome - the Turkish experience.- 19. Induction of specific unresponsiveness (tolerance) to experimental and clinical allografts using polyclonal antilymphocyte serum and donor-specific bone marrow.- 20. Comparison of cyclosporine assays using radioimmunoassay, fluorescent polarization immunoassay and high-performance liquid chromatography.- Five: Renal Transplantation.- 21. Long-term outcome in renal transplantation.- 22. Ten-year experience with 500 renal transplants.- 23. Long-term results in recipients of cadaveric renal allografts under cyclosporine therapy.- 24. Transplantation of single and double kidneys from pediatric donors.- 25. ABO-incompatible living related donor transplantation.- 26. The use of single pediatric cadaver kidneys for transplantation into adult recipients.- 27. Living unrelated donor renal transplantation.- 28. Renal transplantation in Tunisia - a three-year experience.- 29. Renal transplantation in children.- 30. Kidney donors - long-term follow up.- 31. Current techniques for permanent vascular access surgery - experience with 930 procedures.- 32. Results of 319 consecutive renal transplants from living related and living unrelated donors in Iran.- Six: Liver Transplantation.- 33. Liver transplantation: current status.- 34. An overview of liver transplantation therapy for children.- 35. Current anesthetic management in clinical liver transplantation.- 36. Risk factors in adult liver transplant recipients.- 37. The concept of reduced-size liver transplantation, including split-liver and living related liver transplantation.- 38. Immunological factors contributing to outcome in liver transplantation.- 39. Transplantation for hepatobiliary malignancies.- 40. The diagnosis and management of massive blood loss during liver transplantation.- 41. Early clinical experience with cluster resection and transplantation for right upper quadrant abdominal malignancy.- Seven: Heart/Heart-Lung Transplants.- 42. Lung transplantation: current techniques and outcomes.- 43. Heart-lung transplantation at the University of Minnesota.- 44. Specificity and sensitivity of the cytoimmunological monitoring (CIM): differentiation between cardiac rejection, viral, bacterial, or fungal infection.- Eight: Pancreas Transplantation.- 45. International Pancreas Transplantation Registry report.- 46. Technique.